Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Echo Therapeutics Inc

+ Add to Watchlist

ECTE:US

2.4100 USD 0.1850 7.13%

As of 20:10:00 ET on 03/27/2015.

Company Profile for Echo Therapeutics Inc (ECTE)

Echo Therapeutics Inc. is a specialty transdermal therapeutics and diagnostics company. The Company develops portfolio of topical formulations of established, FDA approved products using its proprietary Azone dermal penetration technology.

Contact Information

Echo Therapeutics Inc

10 Forge Parkway
Franklin, MA 02038
United States
Phone: 1-508-553-8850
Fax: 1-508-553-8760

Key Executives for Echo Therapeutics Inc (ECTE)

Robert F Doman "Bob"ChairmanScott W HollanderPresident/CEO
Alan W SchoenbartCFO/SecretaryKenneth Gary "Ken"Senior VP:Rsch & Ops
Daniel Sunday "Dan"VP:Manufacturing & Global Supply ChainThomas Bishop "Tom"VP:Product Development
Christine H OlimpioDir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil